0
13
Journal Articles about Antipsychotics Showing 21-40 of 931
Article | May 01, 2009
Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer’s Disease Patients: The CATIE-AD Study
Ling Zheng, M.B.B.S., Ph.D.; Wendy J. Mack, Ph.D.; Karen S. Dagerman, M.S.; John K. Hsiao, M.D.; Barry D. Lebowitz, Ph.D.; Constantine G. Lyketsos, M.D., M.H.S.; T. Scott Stroup, M.D.; David L. Sultzer, M.D.; Pierre N. Tariot, M.D.; Cheryl Vigen, Ph.D.; Lon S. Schneider, M.D.
The American Journal of Psychiatry. 2009 May ; 5(166):583-590
PDFPDF
Article | April 01, 2009
Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127)
Trisha Suppes, M.D., Ph.D.; Eduard Vieta, M.D., Ph.D.; Sherry Liu, Ph.D.; Martin Brecher, M.D.; Björn Paulsson, M.D.; Trial 127 Investigators
The American Journal of Psychiatry. 2009 April ; 4(166):476-488
PDFPDF  |    Data Supplements
Article | March 01, 2009
Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
Dan W. Haupt, M.D.; Lisa C. Rosenblatt, M.D.; Edward Kim, M.D., M.B.A.; Ross A. Baker, Ph.D., M.B.A.; Richard Whitehead, B.S.; John W. Newcomer, M.D.
The American Journal of Psychiatry. 2009 March ; 3(166):345-353
PDFPDF
Article | February 01, 2009
Association of Cerebral Deficits With Clinical Symptoms in Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry and Resting State Functional Connectivity Study
Su Lui, Ph.D.; Wei Deng, M.D.; Xiaoqi Huang, Ph.D.; Lijun Jiang, M.M.; Xiaohong Ma, Ph.D.; Huafu Chen, Ph.D.; Tijiang Zhang, M.D.; Xiuli Li, M.M.; Dongming Li, M.M.; Ling Zou, Ph.D.; Hehan Tang, M.M.; Xiaohong Joe Zhou, Ph.D.; Andrea Mechelli, Ph.D.; David A. Collier, Ph.D.; John A. Sweeney, Ph.D.; Tao Li, M.D., Ph.D.; Qiyong Gong, M.D., Ph.D.
The American Journal of Psychiatry. 2009 February ; 2(166):196-205
PDFPDF
Reviews and Overviews | February 01, 2009
A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
Stefan Leucht, M.D.; Katja Komossa, M.D.; Christine Rummel-Kluge, M.D.; Caroline Corves, M.Sc.; Heike Hunger; Franziska Schmid; Claudia Asenjo Lobos, M.Sc.; Sandra Schwarz; John M. Davis, M.D.
The American Journal of Psychiatry. 2009 February ; 2(166):152-163
PDFPDF  |  CME Activity (3)  |    Data Supplements
Article | November 01, 2008
Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
Linmarie Sikich, M.D.; Jean A. Frazier, M.D.; Jon McClellan, M.D.; Robert L. Findling, M.D.; Benedetto Vitiello, M.D.; Louise Ritz, M.B.A.; Denisse Ambler, M.D.; Madeline Puglia, B.A.; Ann E. Maloney, M.D.; Emily Michael, B.A.; Sandra De Jong, M.D.; Karen Slifka, R.N., C.S.; Nancy Noyes, C.P.N.P., C.S.; Stefanie Hlastala, Ph.D.; Leslie Pierson, M.P.H.; Nora K. McNamara, M.D.; Denise Delporto-Bedoya, M.A.; Robert Anderson, B.S.; Robert M. Hamer, Ph.D.; Jeffrey A. Lieberman, M.D.
The American Journal of Psychiatry. 2008 November ; 11(165):1420-1431
PDFPDF  |    Data Supplements
Article | November 01, 2008
A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia
Robert L. Findling, M.D.; Adelaide Robb, M.D.; Margaretta Nyilas, M.D.; Robert A. Forbes, Ph.D.; Na Jin, M.S.; Svetlana Ivanova, Ph.D.; Ronald Marcus, M.D.; Robert D. McQuade, Ph.D.; Taro Iwamoto, Ph.D.; William H. Carson, M.D.
The American Journal of Psychiatry. 2008 November ; 11(165):1432-1441
PDFPDF
Article | October 01, 2008
Olanzapine in the Treatment of Low Body Weight and Obsessive Thinking in Women With Anorexia Nervosa: A Randomized, Double-Blind, Placebo-Controlled Trial
Hany Bissada, M.D.; Giorgio A. Tasca, Ph.D.; Ann Marie Barber, M.A.; Jacques Bradwejn, M.D.
The American Journal of Psychiatry. 2008 October ; 10(165):1281-1288
PDFPDF  |  CME Activity (3)
Article | October 01, 2008
Efficacy of Adjunctive Aripiprazole to Either Valproate or Lithium in Bipolar Mania Patients Partially Nonresponsive to Valproate/Lithium Monotherapy: A Placebo-Controlled Study
Eduard Vieta, M.D., Ph.D.; Caroline T’joen, M.S.; Robert D. McQuade, Ph.D.; William H. Carson, Jr., M.D.; Ronald N. Marcus, M.D.; Raymond Sanchez, M.D.; Randall Owen, M.D.; Laurence Nameche, M.S., M.B.A.
The American Journal of Psychiatry. 2008 October ; 10(165):1316-1325
PDFPDF  |    Data Supplements
Article | August 01, 2008
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study
Gerhard Gründer, M.D.; Christine Fellows, M.D.; Hildegard Janouschek, M.D.; Tanja Veselinovic, M.D.; Christian Boy, M.D.; Anno Bröcheler, M.D.; Katrin M. Kirschbaum, Ph.D.; Sandra Hellmann; Katja M. Spreckelmeyer, Ph.D.; Christoph Hiemke, Ph.D.; Frank Rösch, Ph.D.; Wolfgang M. Schaefer, M.D., Ph.D.; Ingo Vernaleken, M.D.
The American Journal of Psychiatry. 2008 August ; 8(165):988-995
PDFPDF
Article | July 01, 2008
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial
David L. Sultzer, M.D.; Sonia M. Davis, Dr.P.H.; Pierre N. Tariot, M.D.; Karen S. Dagerman, M.S.; Barry D. Lebowitz, Ph.D.; Constantine G. Lyketsos, M.D., M.H.S.; Robert A. Rosenheck, M.D.; John K. Hsiao, M.D.; Jeffrey A. Lieberman, M.D.; Lon S. Schneider, M.D.; CATIE-AD Study Group
The American Journal of Psychiatry. 2008 July ; 7(165):844-854
PDFPDF  |  CME Activity (3)  |    Data Supplements
Treatment in Psychiatry | July 01, 2008
Postoperative Delirium
Gregory L. Fricchione, M.D.; Shamim H. Nejad, M.D.; Justin A. Esses, M.D.; Thomas J. Cummings, Jr., M.D.; John Querques, M.D.; Ned H. Cassem, M.D.; George B. Murray, M.D.
The American Journal of Psychiatry. 2008 July ; 7(165):803-812
PDFPDF
Article | March 01, 2008
Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
Ren-Rong Wu, M.D.; Jing-Ping Zhao, M.D.; Xiao-Feng Guo, M.D.; Yi-Qun He, M.D.; Mao-Sheng Fang, M.D.; Wen-Bin Guo, M.D.; Jin-Dong Chen, M.D.; Le-Hua Li, M.D.
The American Journal of Psychiatry. 2008 March ; 3(165):352-358
PDFPDF
Treatment in Psychiatry | November 01, 2007
Chronic Restlessness With Antipsychotics
Irene M. Bratti, M.D.; John M. Kane, M.D.; Stephen R. Marder, M.D.
The American Journal of Psychiatry. 2007 November ; 11(164):1648-1654
PDFPDF
Article | October 01, 2007
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Mauricio Tohen, M.D., Dr.P.H.; Ludmila Kryzhanovskaya, M.D., Ph.D.; Gabrielle Carlson, M.D.; Melissa DelBello, M.D., M.S.; Janet Wozniak, M.D.; Robert Kowatch, M.D.; Karen Wagner, M.D., Ph.D.; Robert Findling, M.D.; Daniel Lin, Ph.D.; Carol Robertson-Plouch, D.V.M.; Wen Xu, Ph.D.; Ralf W. Dittmann, M.D., Ph.D.; Joseph Biederman, M.D.
The American Journal of Psychiatry. 2007 October ; 10(164):1547-1556
PDFPDF
Article | October 01, 2007
Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia
Ganesan Venkatasubramanian, M.D.; Seetharamaiah Chittiprol, Ph.D.; Narendran Neelakantachar, M.B.B.S.; Magadi N. Naveen, M.D.; Jagadisha Thirthall, M.D.; Bangalore N. Gangadhar, M.D.; K. Taranath Shetty, Ph.D.
The American Journal of Psychiatry. 2007 October ; 10(164):1557-1560
PDFPDF
Article | October 01, 2007
Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications
Helen C. Kales, M.D.; Marcia Valenstein, M.D., M.S.; H. Myra Kim, Sc.D.; John F. McCarthy, Ph.D.; Dara Ganoczy, M.P.H.; Francesca Cunningham, Pharm.D.; Frederic C. Blow, Ph.D.
The American Journal of Psychiatry. 2007 October ; 10(164):1568-1576
PDFPDF  |  CME Activity (3)
Article | October 01, 2007
Social Cognition and Neurocognition: Effects of Risperidone, Olanzapine, and Haloperidol
Mark J. Sergi, Ph.D.; Michael F. Green, Ph.D.; Clifford Widmark, M.D.; Christopher Reist, M.D.; Stephen Erhart, M.D.; David L. Braff, M.D.; Kimmy S. Kee, Ph.D.; Stephen R. Marder, M.D.; Jim Mintz, Ph.D.
The American Journal of Psychiatry. 2007 October ; 10(164):1585-1592
PDFPDF
Article | October 01, 2007
The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments
Robert W. Buchanan, M.D.; Daniel C. Javitt, M.D., Ph.D.; Stephen R. Marder, M.D.; Nina R. Schooler, Ph.D.; James M. Gold, Ph.D.; Robert P. McMahon, Ph.D.; Uriel Heresco-Levy, M.D.; William T. Carpenter, M.D.
The American Journal of Psychiatry. 2007 October ; 10(164):1593-1602
PDFPDF  |    Data Supplements
Article | October 01, 2007
The Role of Dopamine in Attentional and Memory Biases for Emotional Information
Ayana A. Gibbs, M.D., M.R.C.Psych.; Kris H. Naudts, M.D.; Edgar P. Spencer, Ph.D., F.R.S.C.; Anthony S. David, M.D., F.R.C.Psych.
The American Journal of Psychiatry. 2007 October ; 10(164):1603-1609
PDFPDF  |  CME Activity (3)
Copyright ©
American
Psychiatric
Association